43 results on '"Everitt, Sarah"'
Search Results
2. Cancer researchers’ experiences with and perceptions of research data sharing: Results of a cross-sectional survey
3. Attitudes of people living with cancer towards trial non-publication and research participation
4. What do Australians affected by cancer think about oncology researchers sharing research data: a cross-sectional survey.
5. An epithelial-to-mesenchymal transition induced extracellular vesicle prognostic signature in non-small cell lung cancer
6. How often do cancer researchers make their data and code available and what factors are associated with sharing?
7. Imaging immunity in patients with cancer using positron emission tomography
8. How often do cancer researchers make their data and code available and what factors are associated with sharing?
9. Please Place Your Seat in the Full Upright Position: A Technical Framework for Landing Upright Radiation Therapy in the 21st Century
10. Blood-Derived Extracellular Vesicle-Associated miR-3182 Detects Non-Small Cell Lung Cancer Patients
11. Predicting muscle loss during lung cancer treatment (PREDICT): protocol for a mixed methods prospective study
12. Nodal metabolic tumour volume on baseline 18F‐FDG PET/CT and overall survival in stage II and III NSCLC patients undergoing curative‐intent chemoradiotherapy/radiotherapy
13. Characterizing the Heterogeneity of Small Extracellular Vesicle Populations in Multiple Cancer Types via an Ultrasensitive Chip
14. A Deep Learning Model to Automate Skeletal Muscle Area Measurement on Computed Tomography Images
15. Non-small cell lung cancer stage migration as a function of wait times from diagnostic imaging: A pooled analysis from five international centres
16. Upright Radiation Therapy—A Historical Reflection and Opportunities for Future Applications
17. Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?
18. PET-detected pneumonitis following curative-intent chemoradiation in non-small cell lung cancer (NSCLC): recognizing patterns and assessing the impact on the predictive ability of FDG-PET/CT response assessment
19. Early Skeletal Muscle Loss in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation and Relationship to Survival
20. What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
21. Treatment Planning for Radiation Therapy
22. Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization
23. Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse Survival
24. Acute radiation oesophagitis associated with 2-deoxy-2-[18F]fluoro-d -glucose uptake on positron emission tomography/CT during chemo-radiation therapy in patients with non-small-cell lung cancer
25. MA13.09 Serial FDG and FLT PET/CT during Curative-Intent Chemo-Radiotherapy for NSCLC Impacts Patient Management and May Predict Clinical Outcomes
26. Cone-beam computed tomography for lung cancer - validation with CT and monitoring tumour response during chemo-radiation therapy
27. Multiple training interventions significantly improve reproducibility of PET/CT-based lung cancer radiotherapy target volume delineation using an IAEA study protocol
28. Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer
29. Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy
30. Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning
31. The Evolving Role of Molecular Imaging in Non–Small Cell Lung Cancer Radiotherapy
32. Geographic miss of lung tumours due to respiratory motion: a comparison of 3D vs 4D PET/CT defined target volumes
33. Effect of Platinum-Based Chemoradiotherapy on Cellular Proliferation in Bone Marrow and Spleen, Estimated by 18F-FLT PET/CT in Patients with Locally Advanced Non–Small Cell Lung Cancer
34. Differential 18F-FDG and 18F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non–Small Cell Lung Cancer
35. Predicting Esophagitis After Chemoradiation Therapy for Non-Small Cell Lung Cancer: An Individual Patient Data Meta-Analysis
36. The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: Results of a prospective study with mature survival data
37. The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancer
38. Distribution of Proliferating Bone Marrow in Adult Cancer Patients Determined Using FLT-PET Imaging
39. High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer
40. Reproducibility of “Intelligent” Contouring of Gross Tumor Volume in Non–Small-Cell Lung Cancer on PET/CT Images Using a Standardized Visual Method
41. Systems and people under pressure: the discharge process in an acute hospital
42. Role of PET-CT in the Optimization of Thoracic Radiotherapy
43. Role of PET-CT in the Optimization of Thoracic Radiotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.